Wealth Quarterback’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Buy |
19,816
+3,795
| +24% | +$262K | 0.65% | 36 |
|
|
2025
Q1 | $1.11M | Buy |
16,021
+3,660
| +30% | +$254K | 0.63% | 35 |
|
|
2024
Q4 | $1.06M | Buy |
12,361
+5,174
| +72% | +$445K | 0.5% | 42 |
|
|
2024
Q3 | $856K | Buy |
+7,187
| New | +$856K | 0.45% | 50 |
|
|
2021
Q3 | $45K | Buy |
924
+264
| +40% | +$12.9K | 0.03% | 254 |
|
|
2021
Q2 | $28K | Buy |
+660
| New | +$28K | 0.02% | 304 |
|
|
2020
Q2 | – | Sell |
-644
| Closed | -$19.4K | – | 543 |
|
|
2020
Q1 | $19.4K | Sell |
644
-100
| -13% | -$3.01K | 0.02% | 342 |
|
|
2019
Q4 | $21.5K | Buy |
+744
| New | +$21.5K | 0.02% | 339 |
|